Citius Oncology Inc.CTORNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P36
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-10.76%
Q3 20256.95%
Q2 202530.58%
Q1 2025-16.16%
Q4 20242.26%
Q3 2024-42.74%
Q2 20241.30%
Q1 2024-2.29%
Q4 20238.87%
Q3 2023-90.19%
Q2 20236.89%
Q1 2023-58.14%
Q4 202278.38%
Q3 2022-272.80%
Q2 20220.00%